Litcius/Paper detail

4-Hexylresorcinol induced angiogenesis potential in human endothelial cells

Min-Keun Kim, Seong‐Gon Kim, Suk Keun Lee

2020Maxillofacial Plastic and Reconstructive Surgery29 citationsDOIOpen Access PDF

Abstract

BACKGROUND: 4-Hexylresorcinol (4HR) is able to increase angiogenesis. However, its molecular mechanism in the human endothelial cells has not been clarified. METHODS: As endothelial cells are important in angiogenesis, we treated the human umbilical vein endothelial cells (HUVECs) with 4HR and investigated protein expressional changes by immunoprecipitation high-performance liquid chromatography (IP-HPLC) using 96 antisera. RESULTS: Here, we found that 4HR upregulated transforming growth factor-β (TGF-β)/SMAD/vascular endothelial growth factor (VEGF) signaling, RAF-B/ERK and p38 signaling, and M2 macrophage polarization pathways. 4HR also increased expression of caspases and subsequent cellular apoptosis. Mechanistically, 4HR increased TGF-β1 production and subsequent activation of SMADs/VEGFs, RAF-B/ERK and p38 signaling, and M2 macrophage polarization. CONCLUSION: Collectively, 4HR activates TGF-β/SMAD/VEGF signaling in endothelial cells and induced vascular regeneration and remodeling for wound healing.

Topics & Concepts

AngiogenesisSMADUmbilical veinCell biologyMedicineTransforming growth factorp38 mitogen-activated protein kinasesVascular endothelial growth factorMAPK/ERK pathwayMacrophage polarizationSignal transductionMacrophageCancer researchBiologyVEGF receptorsBiochemistryIn vitroAngiogenesis and VEGF in CancerCancer, Hypoxia, and MetabolismImmune cells in cancer
4-Hexylresorcinol induced angiogenesis potential in human endothelial cells | Litcius